Neutron Science News & Highlights | Neutron Science at ORNL

This image shows the active site of hCA II. The active site is flanked by hydrophilic (violet) and hydrophobic (green) binding pockets that can be used to design specific drugs targeting cancer-associated hCAs. Five clinical drugs are shown superimposed in the hCA II active site, based on room-temperature neutron structures. (ORNL/Andrey Kovalevsky)

Neutron Study of Glaucoma Drugs Offers Clues About Enzyme Targets for Aggressive Cancers

Recent News & Highlights

UT-ORNL team makes first particle accelerator beam measurement in six dimensions
SNS completes full neutron production cycle at record power level
Gold ore’s chemical cousin helps reveal family secrets
Neutrons analyze advanced high-strength steels to improve vehicle safety and efficiency
$ORNL Instrument Scientist Clarina de la Cruz used the HB-2A Neutron Powder Diffractometer at the High Flux Isotope Reactor to analyze a cobalt-doped thermoelectric material boasting a record increase in room-temperature performance. (Image credit: ORNL/Genevieve Martin)$

Scientists use neutrons to take a deeper look at record boost in thermoelectric efficiency
A History of Neutron Scattering at ORNL
Robust MOF material exhibits selective, fully reversible and repeatable capture of toxic atmospheric gas
ORNL ramps up production of key radioisotope for cancer-fighting drug